Trump policies, China's biotech boom are ending Europe's pharma powerhouse era

Companies have long lamented Europe's fragmented capital markets, single-market adoption on pricing and clinical trials, and uneven reimbursement policies.

# Trump policies, China's biotech boom are ending Europe's pharma powerhouse era Companies have long lamented Europe's fragmented capital markets, single-market adoption on pricing and clinical trials, and uneven reimbursement policies. **Read the full article:** [CNBC](https://www.cnbc.com/2026/04/11/trump-pharma-tariffs-mfn-china-europe-biotech-stocks.html) *This article was originally published by CNBC. MoneyWiseInc provides expert curation of the best financial content from trusted sources.*